
Keywords: GLP-1, Glucagon-like peptide 1; GLP-1R, GLP-1 receptor; CT, Calcitonin; bCT, basal Calcitonin; sCT, stimulated Calcitonin; T2DM, Type 2 diabetes mellitus; CCH, C-cells hyperplasia; MTC, Medullary thyroid cancer; OAD, Oral antidiabetics; FAT, Fat mass; FFM